Results 91 to 100 of about 9,532 (200)

Anti-Osteoporotic Medication-Related Jaw Osteonecrosis: A Descriptive Analysis of the European EudraVigilance Database

Acta Médica Portuguesa
Sofia Ferreira Azevedo, Cláudia Pinto Oliveira, Ana Rita Prata, Inês Cunha, Anabela Barcelos   +4 more
doaj   +1 more source

Short-term anabolic agent and sequential therapy to improve bone mineral density and bone turnover markers in patients with osteoporotic hip fractures. [PDF]

J Orthop Surg Res
Park JY, Lim JY, Kim TK, Cho BW, Kwon HM, Park KK, Lee WS.   +6 more
europepmc   +1 more source

Stimuli‐Responsive 3D‐Printed Structurally Colored Materials Based on Core–Shell Particle Architectures

Macromolecular Materials and Engineering, EarlyView.
A novel, structurally colored and pH‐responsive filament for FDM 3D‐printing is presented, which is based on tailored core–shell particles with methacrylic acid as a comonomer in the particle shell. The pH‐responsiveness of the printed objects is achieved due to particle swelling in alkaline conditions.
Sascha Verwaayen, Lukas Siegwardt, Georg Hemkemeier, Armin W. Novak, Daniel Rauber, Marc Schneider, Markus Gallei   +6 more
wiley   +1 more source

Clinical outcomes of twice-weekly teriparatide acetate administration in osteoporosis. [PDF]

Arch Osteoporos
Tominaga A, Maruki H, Wada K, Terayama Y, Nishi H, Kato Y, Okazaki K.   +6 more
europepmc   +1 more source

3D Polymeric Nanonetworks: From Self‐Assembly to Advanced Fabrication

Macromolecular Materials and Engineering, EarlyView.
This review provides the first systematic cross‐method comparison of fabrication techniques for 3D polymeric nanonetworks. It evaluates five key strategies—block copolymer self‐assembly, hyper‐crosslinking, template‐assisted methods, 3D printing, and nanolithography—across critical metrics including resolution, throughput, scalability, and material ...
Carlos G. Cobos, Xiang Yan, Marisol Martín‐González   +2 more
wiley   +1 more source

Comparative study on the efficacy of menadione, zoledronic acid, and calcitriol in combination with PKP for the treatment of osteoporotic vertebral compression fractures in extremely elderly patients. [PDF]

Medicine (Baltimore)
Yu H, Hou H, Jin Y.
europepmc   +1 more source

Circadian Immunity and Vascular Inflammation in Cardiovascular Disease Chronotherapy Windows: Time for a Re‐Assessment

Med Research, EarlyView.
ABSTRACT Circadian rhythms orchestrate cardiovascular physiology by regulating immune and inflammatory pathways. Disruption of these rhythms profoundly alters vascular homeostasis, thereby promoting the onset and progression of cardiovascular diseases (CVD).
Tian Zhang, Ge Zhang, Tian‐Ding Liu, Tianshu Gu, Fengyi Yu, Pengyuan Xu, Wunan Mi, Xuanjiang Zhao, Qian Guo, Honglin Zheng, Taiqi Zhao, Qiang Li, Di Lu, Mingxuan Duan, Chaoyang Yu, Ruhao Wu, Shiqian Zhang, Haonan Zhang, Zeyu Wang, Youyang Zheng, Yan Xiao, Zenglei Zhang, Ge Zhang   +22 more
wiley   +1 more source

⁹⁹Tc-MDP maintains bone mineral density for postmenopausal differentiated thyroid cancer patients with osteopenia under thyroid-stimulating hormone suppression. [PDF]

Front Endocrinol (Lausanne)
Zhang Y, Wang Y, Sun D, Ma C.
europepmc   +1 more source

Human Cyclophilins—An Emerging Class of Drug Targets

Medicinal Research Reviews, EarlyView.
ABSTRACT Cyclophilins are a family of enzymes with peptidyl‐prolyl isomerase activity found in all cells of all organisms. To date, 17 cyclophilin isoforms have been identified in the human body, participating in diverse biological processes. Consequently, cyclophilins have emerged as promising targets for drug development to address a wide array of ...
Katarina Jurkova, Hana Navratilova, Kamil Musilek, Ondrej Benek   +3 more
wiley   +1 more source

Modern Strategies for Osteoporosis Therapy: Current Status and Prospects for Targeted Intervention. [PDF]

Int J Mol Sci
Omelchenko V, Koval V, Slazhneva N, Bondarenko N, Shatunova E, Vorobyeva M, Korolev M.   +6 more
europepmc   +1 more source